Abbott To File In Thailand For Kaletra Pediatric AIDS Indication
This article was originally published in PharmAsia News
Executive Summary
In an apparent change of position, Abbott will file for approval of a pediatric formulation of its antiretroviral protease inhibitor Kaletra (lopinavir/ritonavir) tablets in Thailand, the firm announced July 27